When someone walks into an emergency room with symptoms of a stroke, every second matters. But today, diagnosing the type of ...
A/B testing, once heralded as the gold standard for data-driven decision-making, often slows companies down due to an ...
Zacks Investment Research on MSN
Hologic's BCI test shows growing impact in endocrine therapy decisions
Hologic’s HOLX acquisition of Biotheranostics in 2021 accelerated its entry into a large, fast-growing oncology adjacency. The business also carries higher margins than the company’s legacy service ...
From the early use of radioiodine to the expanding reach of prostate-specific membrane antigen and somatostatin receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results